Tarsier Pharma Ltd. (TARX)

Tarsier Pharma Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year Ending	Dec 31, 2025	Dec 31, 2024
Cash & Equivalents	2	1.22
Cash & Cash Equivalents	2	1.22
Cash Growth	64.12%	-
Other Current Assets	0.02	0.05
Total Current Assets	2.02	1.27
Property, Plant & Equipment	0.02	0.02
Other Long-Term Assets	0.29	0
Total Long-Term Assets	0.31	0.02
Total Assets	2.33	1.29
Accounts Payable	0.7	0.46
Current Debt	0.12	0.1
Total Current Liabilities	0.81	0.56
Long-Term Debt	6.5	3.49
Total Long-Term Liabilities	6.5	3.49
Total Liabilities	7.32	4.05
Total Debt	6.62	3.6
Debt Growth	84.17%	-
Retained Earnings	-26.93	-21.86
Shareholders' Equity	-4.99	-2.77
Net Cash (Debt)	-4.62	-2.38
Working Capital	1.2	0.71

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).